Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study.

Abstract

BACKGROUND:

Non steroidal anti-inflammatory drugs (NSAIDs) increase mortality and morbidity after myocardial infarction (MI). We examined cause-specific mortality and morbidity associated with NSAIDs in a nationwide cohort of MI patients.

METHODS AND RESULTS:

By individual-level linkage of nationwide registries of hospitalization and drug dispensing from pharmacies in Denmark, patients aged >30 years admitted with first-time MI during 1997-2009 and their subsequent NSAID use were identified. The risk of three cardiovascular specific endpoints: cardiovascular death, the composite of coronary death and nonfatal MI, and the composite of fatal and nonfatal stroke, associated with NSAID use was analyzed by Cox proportional hazard analyses. Of 97,698 patients included 44.0% received NSAIDs during follow-up. Overall use of NSAIDs was associated with an increased risk of cardiovascular death (hazard ratio [HR] 1.42, 95% confidence interval [CI] 1.36-1.49). In particular use of the nonselective NSAID diclofenac and the selective cyclooxygenase-2 inhibitor rofecoxib was associated with increased risk of cardiovascular death (HR 1.96 [1.79-2.15] and HR1.66 [1.44-1.91], respectively) with a dose dependent increase in risk. Use of ibuprofen was associated with increased risk of cardiovascular death (HR 1.34[1.26-1.44]), whereas naproxen was associated with the lowest risk of (e.g., HR 1.27[1.01-1.59].

CONCLUSION:

Use of individual NSAIDs is associated with different cause-specific cardiovascular risk and in particular rofecoxib and diclofenac were associated with increased cardiovascular morbidity and mortality. These results support caution with use of all NSAIDs in patients with prior MI.

• Authors: Anne-Marie Schjerning Olsen, Emil L Fosbøl, Jesper Lindhardsen, Charlotte Andersson, Fredrik Folke, Mia B Nielsen, Lars Køber, Peter R Hansen, Christian Torp-Pedersen, Gunnar H Gislason
• Journal: PloS one (PLoS One) Vol. 8 Issue 1 Pg. e54309 ( 2013) ISSN: 1932-6203 [Electronic] United States
• PMID: 23382889 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Lactones
• Sulfones
• rofecoxib
• Diclofenac

Topics

• Aged
• Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, adverse effects)
• Denmark
• Diclofenac (administration & dosage, adverse effects)
• Female
• Follow-Up Studies
• Hospitalization
• Humans
• Lactones (administration & dosage, adverse effects)
• Male
• Middle Aged
• Myocardial Infarction (drug therapy, mortality, pathology)
• Proportional Hazards Models
• Registries
• Risk Factors
• Sulfones (administration & dosage, adverse effects)